For instance, PHB2 acts as a tumour suppressor in breast cancer by interacting with estrogen receptor-alpha (ERα) in the nucleus, where it functions as a corepressor, inhibiting ERα-mediated transcription and proliferation [17]. Here, ESR1 is linked to breast carcinoma.